Skip to Content

Join the 'Herpes Simplex - Suppression' group to help and get support from people like you.

Herpes Simplex - Suppression News

Related terms: Genital Herpes

Pubic Grooming Tied to Higher STD Rates

Posted 2 days 1 hour ago by Drugs.com

MONDAY, Dec. 5, 2016 – Brazilian bikini waxing and similar forms of personal grooming may be all the rage, but they come with a heightened risk of acquiring a sexually transmitted disease, new research suggests. The study found that frequent groomers of pubic hair are three to four times more likely to contract a sexually transmitted infection, such as herpes, human papillomavirus (HPV) or syphilis. "Grooming is linked to a heightened self-reported sexually transmitted disease risk, and for those who groom frequently or remove all of their hair often, the association is even higher," said lead researcher Dr. Charles Osterberg. He's an assistant professor of urology and surgery at the University of Texas Dell Medical School in Austin. Still, the study didn't prove a direct cause-and-effect relationship between pubic grooming and sexually transmitted infections, it was only designed to ... Read more

Related support groups: Sexually Transmitted Diseases, Cold sores, Herpes Simplex - Suppression, Herpes Simplex, Human Papilloma Virus, Syphilis, Herpes Simplex Labialis, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Cervical Dysplasia, Tertiary Syphilis, Human Papillomavirus Prophylaxis, Syphilis - Early, Neurosyphilis, Syphilis - Latent, Herpes Simplex - Prophylaxis

Injections Might Help Prevent Genital Herpes Transmission for Months: Study

Posted 3 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 2, 2016 – Three injections of a therapeutic vaccine may control genital herpes as effectively as daily pills for at least a year, a new study suggests. Researchers tested the experimental vaccine in 310 people with herpes from 17 centers around the United States. The three shots, administered three weeks apart, appeared to reduce patients' genital lesions and the process of "viral shedding" in which they can spread the disease through sexual contact. Infectious disease experts hailed the vaccine as a promising development in the treatment of genital herpes. The incurable disease affects about one in every six people ages 14 to 49 in the United States, according to the U.S. Centers for Disease Control and Prevention. "In general terms, people receiving [the vaccine] have greater than 50 percent fewer days in which virus is present in their genital tracts, which in theory ... Read more

Related support groups: Sexually Transmitted Diseases, Herpes Simplex - Suppression, Herpes Simplex, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Diagnosis and Investigation, Herpes Simplex - Prophylaxis

Task Force: Routine Genital Herpes Screening Not Recommended

Posted 2 Aug 2016 by Drugs.com

TUESDAY, Aug. 2, 2016 – A U.S. federal task force is prepared to recommend that teens, adults and pregnant women not be routinely tested for genital herpes if they don't have signs of infection. About one in every six Americans between the ages of 14 and 49 has genital herpes, according to the U.S. Centers for Disease Control and Prevention. The disease, which is transmitted through vaginal, anal and oral sex, causes symptoms like blisters, discharge, burning and bleeding between periods. Though symptoms can be treated, genital herpes is incurable. In support of its proposed guidelines, the U.S. Preventive Services Task Force says the benefit of routine herpes screening is small, because early treatments aren't likely to make much of a difference. "Because there's no cure, there isn't much doctors and nurses can do for people who don't have symptoms," Dr. Maureen Phipps said in a news ... Read more

Related support groups: Sexually Transmitted Diseases, Cold sores, Herpes Simplex - Suppression, Herpes Simplex, Herpes Simplex Labialis, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Herpes Simplex, Mucocutaneous/Immunocompromised Host, Herpes Simplex - Prophylaxis, Herpes Simplex Otitis Externa

Experimental Genital Herpes Drug Shows Promise

Posted 20 Jun 2016 by Drugs.com

MONDAY, June 20, 2016 – An experimental immune-boosting treatment for genital herpes shows promise, researchers report. The drug, called GEN-003, may reduce both virus activity and the number of days with recurrent herpes in patients. The treatment is given in a series of three injections and appears to last for up to one year, the investigators said. The researchers tested the vaccine on 310 people with a history of chronic, recurrent genital herpes. The findings were to be presented Monday at an American Society for Microbiology meeting in Boston. Research presented at meetings is considered preliminary until published in a peer-reviewed journal. The study was funded by Genocea Biosciences, the Cambridge, Mass.-based company that makes the drug. "GEN-003 is believed to work through a different pathway from most vaccines by recruiting T-cells, which are critical to controlling chronic ... Read more

Related support groups: Sexually Transmitted Diseases, Herpes Simplex - Suppression, Herpes Simplex, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Herpes Simplex - Prophylaxis

Many Americans Under 50 Living With Cold Sore Virus

Posted 11 May 2015 by Drugs.com

SATURDAY, May 9, 2015 – More than half of Americans aged 14 to 49 carry the virus that causes cold sores – those small blisters around the mouth that may come and go, according to the American Academy of Dermatology (AAD). "Cold sores may appear just once in a person's lifetime or return again and again," said Dr. Bruce Brod, a clinical professor of dermatology at the University of Pennsylvania, Perelman School of Medicine in Philadelphia, in an AAD news release. Cold sores are caused by a virus that stays in the body, even when there are no active cold sores, according to the AAD. Sometimes people mistake cold sores for canker sores. But canker sores aren't caused by a virus, and they occur inside – rather than outside – the mouth, according to Brod. Certain factors can trigger cold sores. The list includes stress and fatigue, sun exposure, cold and flu, fever, hormonal changes due ... Read more

Related support groups: Anxiety and Stress, Acyclovir, Cold sores, Herpes Simplex - Suppression, Herpes Simplex, Zovirax, Herpes Simplex Labialis, Famciclovir, Famvir, Zovirax Cream, Sitavig, Denavir, Herplex, Penciclovir, Zovirax Topical, Acyclovir/Hydrocortisone, Xerese, Idoxuridine, Zovirax Ointment, Herpes Simplex - Prophylaxis

New STD Report Finds Some Progress, High Costs for U.S.

Posted 23 Nov 2010 by Drugs.com

MONDAY, Nov. 22 – The approximately 19 million new sexually transmitted disease (STD) infections that occur each year in the United States cost the health care system about $16.4 billion annually, the U.S. Centers for Disease Control and Prevention said in its annual STD report released Monday. The data for 2009 shows a continued high burden of STDs but there are some signs of progress, according to the report, which focuses on chlamydia, gonorrhea and syphilis. The national rate of reported gonorrhea cases stands at 99 cases per 100,000 people, its lowest level since record keeping started in 1941, and cases are declining among all racial/ethnic groups (down 17 percent since 2006). Since 2006, chlamydia infections have increased 19 percent to about 409 per 100,000 people. However, the report suggests that this indicates more people than ever are being screened for chlamydia, which is ... Read more

Related support groups: HIV Infection, Sexually Transmitted Diseases, Chlamydia Infection, Herpes Simplex - Suppression, Trichomoniasis, Herpes Simplex, Human Papilloma Virus, Condylomata Acuminata, Gonococcal Infection - Uncomplicated, Syphilis, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Herpes Simplex, Mucocutaneous/Immunocompromised Host, Herpes Simplex Encephalitis, Cervical Dysplasia, Gonococcal Infection - Disseminated, Gonococcal Infection, Tertiary Syphilis, Congenital Syphilis, Trachoma, Syphilis - Early

FDA Medwatch Alert: Unapproved Over The Counter Drugs Marketed for Prevention and Treatment of STDs

Posted 6 Mar 2008 by Drugs.com

[Posted 03/06/2008] FDA advised healthcare professionals and consumers that the Agency issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the internet to U.S. consumers for the prevention and treatment of sexually transmitted diseases (STDs). The products are marketed under the names Tetrasil, Genisil, Aviralex, OXi-MED, Imulux, Beta-mannan, Micronutrient, Qina, and SlicPlus. The products claim to prevent or treat a variety of STDs, including Herpes, Chlamydia, Human Papilloma Virus, cervical dysplasia, and HIV/AIDS. The products pose a serious health threat to unsuspecting consumers who don't know that these products are not FDA approved and have not been proven safe or effective. Consumers who are currently using these products should stop using them immediately and consult their healthcare professional if they ... Read more

Related support groups: HIV Infection, Chlamydia Infection, Herpes Simplex - Suppression, Human Papilloma Virus, Cervical Dysplasia, Human Papillomavirus Prophylaxis, Herpes Simplex - Prophylaxis

Ask a Question

Further Information

Related Condition Support Groups

Herpes Simplex

Related Drug Support Groups

Valtrex, acyclovir, valacyclovir, Zovirax, lysine, famciclovir, Famvir, L-Lysine